{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:17:38Z","timestamp":1780085858330,"version":"3.54.0"},"reference-count":429,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T00:00:00Z","timestamp":1330905600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:italic>Psoriasis vulgaris is a common and often chronic inflammatory skin disease.<\/jats:italic>The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence\u2010based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque\u2010type psoriasis in adults including systemic therapy, UV therapy and topical therapies.<\/jats:p><jats:p>The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).<\/jats:p>","DOI":"10.1111\/j.1610-0387.2012.07919.x","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T22:42:17Z","timestamp":1330987337000},"source":"Crossref","is-referenced-by-count":196,"title":["S3 \u2013 Guidelines on the treatment of psoriasis vulgaris (English version). Update"],"prefix":"10.1111","volume":"10","author":[{"given":"Alexander","family":"Nast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf\u2010Henning","family":"Boehncke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Mrowietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans\u2010Michael","family":"Ockenfels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Sammain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Sterry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Streit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Koza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegrid","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans\u2010Dieter","family":"Orzechowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Rosumeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Schmid\u2010Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Weberschock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Rzany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,5]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1035.x"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-005-0906-9"},{"key":"e_1_2_15_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70112-X"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1087-0024.2003.09102.x"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)80057-7"},{"key":"e_1_2_15_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.4.408"},{"key":"e_1_2_15_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01565.x"},{"key":"e_1_2_15_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2008.00971.x"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02841.x"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2005.05729.x"},{"key":"e_1_2_15_12_2","first-page":"1\u201415","volume-title":"Gesundheitsbe\u2010 richterstattung des Bundes","author":"Traupe H","year":"2002"},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.10.024"},{"key":"e_1_2_15_14_2","doi-asserted-by":"crossref","first-page":"65\u20146","DOI":"10.1111\/j.1610-0387.2009.07312.x","article-title":"Evidence\u2010based (S3) guideline for the treatment of psoriasis vulgaris \u2013 Update: \u201cTherapeutic options\u201d and \u201cEfalizumab\u201d","volume":"8","author":"Nast A","year":"2010","journal-title":"J Dtsch Dermatol Ges."},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0744-y"},{"issue":"2","key":"e_1_2_15_16_2","first-page":"S1\u2014126","article-title":"[S3\u2010Guidelines for the therapy of psoriasis vulgaris]","volume":"4","author":"Nast A","year":"2006","journal-title":"J Dtsch Dermatol Ges."},{"issue":"3","key":"e_1_2_15_17_2","first-page":"1\u2014119","article-title":"Evidence\u2010based (S3) guidelines for the treatment of psoriasis vulgaris","volume":"5","author":"Nast A","year":"2007","journal-title":"J Dtsch Dermatol Ges."},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09505.x"},{"key":"e_1_2_15_19_2","unstructured":"Van Zuiden Communications (Hrsg.).Richtlijn foto(chemo)therapie en sy\u2010 stemische therapie bij ernstige chronische plaque psoriasis.2003."},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.04713.x"},{"key":"e_1_2_15_21_2","unstructured":"AugustinM.Pharmako\u2010Okonomische Angaben. Stand Juli 2010."},{"key":"e_1_2_15_22_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0770"},{"key":"e_1_2_15_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07675.x"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.09023.x"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-006-0707-8"},{"key":"e_1_2_15_26_2","first-page":"225\u201430","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris L","year":"2004","journal-title":"Eur J Epidemiol."},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.14.1735"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07986.x"},{"key":"e_1_2_15_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.12.1493"},{"key":"e_1_2_15_30_2","first-page":"321\u20148","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer DM","year":"2006","journal-title":"Archives of Der- matological Research."},{"key":"e_1_2_15_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07562.x"},{"key":"e_1_2_15_32_2","first-page":"21\u201436","article-title":"Impact of comorbidities on the management of psoriasis","volume":"38","author":"Gerdes S","year":"2009","journal-title":"Curr probl dermatol."},{"key":"e_1_2_15_33_2","doi-asserted-by":"crossref","first-page":"885\u201492","DOI":"10.1111\/j.1468-3083.2009.03537.x","article-title":"Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population\u2010based sample","volume":"24","author":"Schmitt J","year":"2010","journal-title":"Journal of the European Academy of Dermatology & Venereology."},{"key":"e_1_2_15_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05115.x"},{"key":"e_1_2_15_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22590"},{"key":"e_1_2_15_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/511051"},{"key":"e_1_2_15_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-007-0397-0"},{"key":"e_1_2_15_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804595"},{"key":"e_1_2_15_39_2","article-title":"Definition of treatment goals for moderate to severe psoriasis: a European consensus","author":"Mrowietz U","year":"2010","journal-title":"Archives of Dermatological Research."},{"key":"e_1_2_15_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06240.x"},{"key":"e_1_2_15_41_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1684\/ejd.2010.0815","article-title":"Concordance of the Psoriasis Area and Severity Index (PASI) and patient\u2010reported outcomes in psoriasis treatment","volume":"20","author":"Schafer I","year":"2010","journal-title":"Eur J Dermatol."},{"key":"e_1_2_15_42_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-813336"},{"key":"e_1_2_15_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09593.x"},{"key":"e_1_2_15_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000119415"},{"key":"e_1_2_15_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.07.022"},{"key":"e_1_2_15_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.09.018"},{"key":"e_1_2_15_47_2","article-title":"Cost Effectiveness of Biologic Therapy in Remission Induction of Moderate to Severe Plaque Psoriasis","author":"Schmitt\u2010Rau K","journal-title":"Dermatology."},{"key":"e_1_2_15_48_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106791"},{"key":"e_1_2_15_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2008.06919_supp.x"},{"key":"e_1_2_15_50_2","unstructured":"Anonymous. Salicylsaure zur topischen Anwendung. Bundesanzeiger. 19.06.1990 Korrektur 20.09.1990 (korrigierte Fassung in ZrvA Dez 1990)."},{"key":"e_1_2_15_51_2","article-title":"Expertise zu Wirksamkeit und Nutzen von Harnstoff in der Therapie chronischer Hautkrankheiten. Wissenschaftliches Gutachten im Auftrag der Deutschen Dermatologischen Gesellschaft","author":"Augustin M","year":"2004","journal-title":"Hamburg"},{"key":"e_1_2_15_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/b137790"},{"key":"e_1_2_15_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470750704"},{"key":"e_1_2_15_54_2","volume-title":"Psoriasis \u2013 auf einen Blick","author":"Christophers E","year":"2002"},{"key":"e_1_2_15_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-06555-6"},{"key":"e_1_2_15_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-07131-1"},{"key":"e_1_2_15_57_2","volume-title":"Therapeutische Verfahren in der Dermatologie. 1. Edition","author":"Korting HC","year":"2001"},{"key":"e_1_2_15_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00500.x"},{"key":"e_1_2_15_59_2","volume-title":"Treatment of Skin Disease","author":"Lebwohl M","year":"2002"},{"key":"e_1_2_15_60_2","volume-title":"Arzneimittelverordnungen. Im Auftrag der Arzneimittelkommission der Deutschen Arzteschaft","author":"Muller\u2010Oerlinghausen","year":"2003"},{"key":"e_1_2_15_61_2","volume-title":"Derma\u2010 tika.","author":"Niedner R","year":"1992"},{"key":"e_1_2_15_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-56219-8"},{"key":"e_1_2_15_63_2","volume-title":"Padiatrische Dermatologie.","author":"Traupe H","year":"1999"},{"key":"e_1_2_15_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987421"},{"key":"e_1_2_15_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1986.tb00457.x"},{"key":"e_1_2_15_66_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2340\/0001555576353356","article-title":"Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis","volume":"76","author":"Hagemann I","year":"1996","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_67_2","first-page":"438","article-title":"A randomized comparison of three conventional modes of treatment of psoriasis of the scalp","volume":"28","author":"Ross SD","year":"1981","journal-title":"Cutis."},{"key":"e_1_2_15_68_2","first-page":"123","article-title":"A new treatment of ichthyosis and other hyperkeratotic conditions","volume":"48","author":"Swanbeck G","year":"1968","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_69_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02554.x"},{"key":"e_1_2_15_70_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02927.x"},{"key":"e_1_2_15_71_2","first-page":"1101\u20142","article-title":"Topical tacrolimus is not effective in chronic plaque psoriasis","volume":"134","author":"Zonneveld IM","year":"1998","journal-title":"A pilot study. Arch Dermatol."},{"key":"e_1_2_15_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.01054.x"},{"key":"e_1_2_15_73_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.169"},{"key":"e_1_2_15_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.06.010"},{"key":"e_1_2_15_75_2","first-page":"419\u201423","article-title":"Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double\u2010blind, placebo\u2010controlled study. The European FK 506 Multicentre Study Group","volume":"132","author":"Anonymous","year":"1996","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_76_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02974.x"},{"key":"e_1_2_15_77_2","first-page":"692\u20144","article-title":"FK\u2010506\u2010 and CsA\u2010sensitive activation of the interleukin\u20102 promoter by calcineurin","volume":"357","author":"O\u2019Keefe SJ","year":"1992","journal-title":"Nature."},{"key":"e_1_2_15_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90124-H"},{"key":"e_1_2_15_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70163-X"},{"key":"e_1_2_15_80_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02225.x"},{"key":"e_1_2_15_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.03.021"},{"key":"e_1_2_15_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08201.x"},{"key":"e_1_2_15_83_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.1.43"},{"key":"e_1_2_15_84_2","doi-asserted-by":"crossref","first-page":"29\u201433","DOI":"10.1080\/00015550510039817","article-title":"0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open\u2010label, observer\u2010blinded study","volume":"86","author":"Ortonne JP","year":"2006","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_85_2","first-page":"334\u20146","article-title":"Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques","volume":"5","author":"Martin Ezquerra G","year":"2006","journal-title":"J Drugs Dermatol."},{"key":"e_1_2_15_86_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310003791"},{"key":"e_1_2_15_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00458.x"},{"key":"e_1_2_15_88_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12274997"},{"key":"e_1_2_15_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1987.tb04920.x"},{"key":"e_1_2_15_90_2","first-page":"338\u201441","article-title":"The effect of anthralin and its derivatives on epidermal cell kinetics","volume":"64","author":"Fisher LB","year":"1975","journal-title":"J Invest Derma- tol."},{"key":"e_1_2_15_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499901"},{"key":"e_1_2_15_92_2","doi-asserted-by":"crossref","first-page":"37\u201440","DOI":"10.2340\/00015555733740","article-title":"Down\u2010regulation of epidermal growth factor receptors by dithranol","volume":"73","author":"Kemeny L","year":"1993","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_93_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01105083"},{"key":"e_1_2_15_94_2","first-page":"8\u201413","article-title":"Anthralin","volume":"11","author":"Lebwohl M","year":"1999","journal-title":"Dermatol Ther."},{"key":"e_1_2_15_95_2","doi-asserted-by":"crossref","first-page":"817\u201433","DOI":"10.1016\/S0733-8635(18)30045-7","article-title":"Tars and anthralins","volume":"13","author":"Silverman A","year":"1995","journal-title":"Dermatol Clin."},{"key":"e_1_2_15_96_2","doi-asserted-by":"crossref","first-page":"295\u20147","DOI":"10.2340\/0001555574298301","article-title":"The systemic effect of dithranol treatment in psoriasis","volume":"74","author":"Goodfield MJ","year":"1994","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_97_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065971"},{"key":"e_1_2_15_98_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1742-1241.1985.tb07812.x","article-title":"A comparison between Antraderm stick (0.5% and 1%) and dithranol paste (0.125% and 0.25%) in the treatment of psoriasis","volume":"39","author":"Agrup G","year":"1985","journal-title":"Br J Clin Pract."},{"key":"e_1_2_15_99_2","doi-asserted-by":"publisher","DOI":"10.1159\/000210784"},{"key":"e_1_2_15_100_2","doi-asserted-by":"publisher","DOI":"10.1159\/000029819"},{"key":"e_1_2_15_101_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018457"},{"issue":"282","key":"e_1_2_15_102_2","first-page":"85","article-title":"[The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis]","volume":"65","author":"Mahrle G","year":"1990","journal-title":"Z Hautkr."},{"key":"e_1_2_15_103_2","doi-asserted-by":"publisher","DOI":"10.1159\/000029933"},{"key":"e_1_2_15_104_2","first-page":"214","article-title":"The impact of the frequency of short contact dithranol treatment","volume":"11","author":"Prins M","year":"2001","journal-title":"Eur J Dermatol."},{"key":"e_1_2_15_105_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04698.x"},{"key":"e_1_2_15_106_2","first-page":"28","article-title":"Short\u2010 and long\u2010 contact therapy using a new dithranol formulation in individually adjusted dosages in the management of psoriasis","volume":"172","author":"Thune P","year":"1992","journal-title":"Acta Derm Venereol Suppl (Stockh)."},{"key":"e_1_2_15_107_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057884"},{"key":"e_1_2_15_108_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07393.x"},{"key":"e_1_2_15_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2002.tb00321.x"},{"key":"e_1_2_15_110_2","first-page":"23","article-title":"An open, parallel groups, study of the importance of thoroughness of application in the treatment of psoriasis with a dithranol cream (Micanol)","volume":"172","author":"Mork NJ","year":"1992","journal-title":"Acta Derm Venereol Suppl (Stockh)."},{"key":"e_1_2_15_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00126.x"},{"key":"e_1_2_15_112_2","doi-asserted-by":"publisher","DOI":"10.1159\/000249273"},{"key":"e_1_2_15_113_2","first-page":"125","article-title":"Irritation and staining by dithranol (anthralin) and related compounds: I. Estimation with chamber testing and contact thermo\u2010 graphy","volume":"59","author":"Mustakallio KK","year":"1979","journal-title":"Acta Derm Venereol Suppl (Stockh)."},{"key":"e_1_2_15_114_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1996.tb02199.x"},{"key":"e_1_2_15_115_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1994.tb01965.x"},{"key":"e_1_2_15_116_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1990.tb125127.x"},{"key":"e_1_2_15_117_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630305545"},{"key":"e_1_2_15_118_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639109086777"},{"key":"e_1_2_15_119_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550252948194"},{"key":"e_1_2_15_120_2","doi-asserted-by":"publisher","DOI":"10.1177\/120347540300700301"},{"key":"e_1_2_15_121_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639809160546"},{"key":"e_1_2_15_122_2","doi-asserted-by":"publisher","DOI":"10.1159\/000066440"},{"key":"e_1_2_15_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80091-X"},{"key":"e_1_2_15_124_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630510041060"},{"key":"e_1_2_15_125_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.130"},{"key":"e_1_2_15_126_2","first-page":"348\u201454","article-title":"Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque\u2010type psoriasis","volume":"78","author":"Jarratt MT","year":"2006","journal-title":"Cutis."},{"key":"e_1_2_15_127_2","first-page":"291\u201496","article-title":"Management of psoriasis: A clinical evaluation of the dermato\u2010 logical patch, Actidermregistered trade mark, over a topical steroid","volume":"5","author":"Bagatell F","year":"1988","journal-title":"Adv Therap."},{"key":"e_1_2_15_128_2","first-page":"357\u201460","article-title":"An intra\u2010individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis","volume":"5","author":"Beutner K","year":"2006","journal-title":"J Drugs Dermatol."},{"key":"e_1_2_15_129_2","first-page":"201\u20146","article-title":"Clobetasol propio\u2010 nate lotion in the treatment of moderate to severe plaque\u2010type psoriasis","volume":"74","author":"Decroix J","year":"2004","journal-title":"Cutis."},{"key":"e_1_2_15_130_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.417"},{"key":"e_1_2_15_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.026"},{"key":"e_1_2_15_132_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01431.x"},{"key":"e_1_2_15_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80094-X"},{"key":"e_1_2_15_134_2","first-page":"52\u20147","article-title":"Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% beta\u2010 methasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis","volume":"8","author":"Menter A","year":"2009","journal-title":"J Drugs Dermatol."},{"key":"e_1_2_15_135_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01387.x"},{"key":"e_1_2_15_136_2","first-page":"223\u20146","article-title":"Comparison of mometa\u2010 sone fluroate 0.1% ointment and be\u2010 tamethasone dipropionate 0.05% ointment in the treatment of psoriasis vulgaris","volume":"8","author":"Peharda V","year":"2000","journal-title":"Acta Derm Venereol Croatica"},{"key":"e_1_2_15_137_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0846.2008.00336.x"},{"key":"e_1_2_15_138_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247323"},{"key":"e_1_2_15_139_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-001-0006-0"},{"key":"e_1_2_15_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(05)80413-8"},{"key":"e_1_2_15_141_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.02932.x"},{"key":"e_1_2_15_142_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12461062"},{"issue":"1","key":"e_1_2_15_143_2","first-page":"26\u201430","article-title":"A comparative multicentre trial of halometasone ointment and fluocortolone plus fluocortolone caproate ointment in the treatment of psoriasis","volume":"11","author":"Fabry H","year":"1983","journal-title":"J Int Med Res."},{"key":"e_1_2_15_144_2","first-page":"751\u20145","article-title":"The efficacy of three class I topical synthetic corticostero\u2010 ids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz\u2010Dumas bio\u2010 assay comparison","volume":"8","author":"Lee CS","year":"2009","journal-title":"J Drugs Dermatol."},{"key":"e_1_2_15_145_2","first-page":"347\u201456","volume-title":"Psoriasis: Proceeding of International Symposium","author":"Grupper C","year":"1971"},{"key":"e_1_2_15_146_2","doi-asserted-by":"crossref","first-page":"840\u20146","DOI":"10.1001\/archderm.1979.04010070016013","article-title":"Tar gel\u2010phototherapy for psoriasis. Combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation","volume":"115","author":"Frost P","year":"1979","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_147_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-006-0723-8"},{"key":"e_1_2_15_148_2","first-page":"351\u20147","article-title":"LCD plus NB\u2010UVB reduces time to improvement of psoriasis vs. NB\u2010UVB alone","volume":"8","author":"Bagel J","year":"2009","journal-title":"J Drugs Dermatol."},{"key":"e_1_2_15_149_2","doi-asserted-by":"crossref","first-page":"319\u201421","DOI":"10.1001\/archderm.1982.01650170033018","article-title":"The role of tar in Goeckerman therapy","volume":"118","author":"Belsito DV","year":"1982","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)70188-5"},{"key":"e_1_2_15_151_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12506317"},{"key":"e_1_2_15_152_2","first-page":"228\u201438","article-title":"Hauptverband der gewerblichen Be\u2010 rufsgenossenschaften e. V. Berufsgenos\u2010 senschaftliche Grundsatze fur arbeits\u2010 medizinische Vorsorgeuntersuchungen bei Einwirkung krebserzeugener Ar\u2010 beitsstoffe","volume":"17","year":"1982","journal-title":"Arbeitsmed, Sozialmed, Praventivmed."},{"key":"e_1_2_15_153_2","first-page":"188\u201495","article-title":"Scrotal cancer in the north\u2010west of England, 1962\u201368","volume":"29","author":"Lee WR","year":"1972","journal-title":"Br J Ind Med."},{"key":"e_1_2_15_154_2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archderm.1984.01650450051017","article-title":"Psoralens and UV\u2010A and UV\u2010B twice weekly for the treatment of psoriasis","volume":"120","author":"Diette KM","year":"1984","journal-title":"Arch Derma- tol."},{"key":"e_1_2_15_155_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.140S54018.x"},{"key":"e_1_2_15_156_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.103"},{"key":"e_1_2_15_157_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-001-0031-z"},{"key":"e_1_2_15_158_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01167.x"},{"key":"e_1_2_15_159_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.108319"},{"key":"e_1_2_15_160_2","first-page":"41","article-title":"Tazarotene 0.1% gel in combination with mometasone furo\u2010 ate cream in plaque psoriasis: a photographic tracking study","volume":"63","author":"Poulin YP","year":"1999","journal-title":"Cutis."},{"key":"e_1_2_15_161_2","doi-asserted-by":"publisher","DOI":"10.1159\/000091250"},{"key":"e_1_2_15_162_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.9.4974"},{"key":"e_1_2_15_163_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4049\/jimmunol.160.1.209","article-title":"Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25\u2010 dihydroxyvitamin D3\u2010mediated effects","volume":"160","author":"Takeuchi A","year":"1998","journal-title":"J Immunol."},{"key":"e_1_2_15_164_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04967.x"},{"key":"e_1_2_15_165_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05986.x"},{"key":"e_1_2_15_166_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080854"},{"key":"e_1_2_15_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83065-9"},{"key":"e_1_2_15_168_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07561.x"},{"key":"e_1_2_15_169_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630701646156"},{"key":"e_1_2_15_170_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01913.x"},{"key":"e_1_2_15_171_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1998.tb00948.x"},{"key":"e_1_2_15_172_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb07608.x"},{"key":"e_1_2_15_173_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200607030-00004"},{"key":"e_1_2_15_174_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2006.00022.x"},{"key":"e_1_2_15_175_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463200501800419"},{"key":"e_1_2_15_176_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200626040-00008"},{"key":"e_1_2_15_177_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0290"},{"key":"e_1_2_15_178_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2007.00275.x"},{"key":"e_1_2_15_179_2","first-page":"110\u20144","article-title":"Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study","volume":"155","author":"Erceg A","year":"2006","journal-title":"Br J Derma- tol."},{"key":"e_1_2_15_180_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70323-8"},{"key":"e_1_2_15_181_2","first-page":"985\u201497","article-title":"[Recommendations for phototherapy and photochemotherapy]","volume":"1","author":"Holzle E","year":"2003","journal-title":"J Dtsch Dermatol Ges."},{"key":"e_1_2_15_182_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018309"},{"key":"e_1_2_15_183_2","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2007.7099"},{"key":"e_1_2_15_184_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02152.x"},{"key":"e_1_2_15_185_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2008.34386.x"},{"key":"e_1_2_15_186_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04074.x"},{"key":"e_1_2_15_187_2","first-page":"256\u20149","article-title":"Different narrowband UVB dosage regimens in dark skinned psoriatics: a preliminary study","volume":"24","author":"Youssef RM","year":"2008","journal-title":"Photodermatol Photoimmunol Pho- tomed."},{"key":"e_1_2_15_188_2","doi-asserted-by":"crossref","first-page":"207\u201410","DOI":"10.1001\/archderm.1983.01650270025011","article-title":"Topical steroids and UV radiation in psoriasis","volume":"119","author":"Petrozzi JW","year":"1983","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_189_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2006.05.011"},{"key":"e_1_2_15_190_2","doi-asserted-by":"crossref","first-page":"1514\u201422","DOI":"10.1001\/archderm.1997.03890480034005","article-title":"Narrowband UV\u2010B produces superior clinical and histopathological resolution of moderate\u2010to\u2010severe psoriasis in patients compared with broadband UV\u2010B","volume":"133","author":"Coven TR","year":"1997","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_191_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310022916"},{"key":"e_1_2_15_192_2","first-page":"285\u20149","article-title":"8\u2010Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis","volume":"22","author":"Amornpinyokeit N","year":"2006","journal-title":"Photodermatol Pho- toimmunol Photomed."},{"key":"e_1_2_15_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70008-3"},{"key":"e_1_2_15_194_2","first-page":"202\u20146","article-title":"Comparison of phototherapy two times and four times a week with low doses of narrow\u2010band ultraviolet B in Asian patients with psoriasis","volume":"16","author":"Leenutaphong V","year":"2000","journal-title":"Photodermatol Photoim- munol Photomed."},{"key":"e_1_2_15_195_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.7.836"},{"key":"e_1_2_15_196_2","doi-asserted-by":"publisher","DOI":"10.1159\/000093852"},{"key":"e_1_2_15_197_2","first-page":"200\u20143","article-title":"Nonlaser UVB\u2010targeted phototherapy treatment of psoriasis","volume":"78","author":"Kaur M","year":"2006","journal-title":"Cutis."},{"key":"e_1_2_15_198_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)00792-8"},{"key":"e_1_2_15_199_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197412052912301"},{"key":"e_1_2_15_200_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310021947"},{"key":"e_1_2_15_201_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb06924.x"},{"key":"e_1_2_15_202_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.125075"},{"key":"e_1_2_15_203_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120454"},{"key":"e_1_2_15_204_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04355.x"},{"key":"e_1_2_15_205_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.5.586"},{"key":"e_1_2_15_206_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02766.x"},{"key":"e_1_2_15_207_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02670.x"},{"key":"e_1_2_15_208_2","first-page":"217","article-title":"Treatment of psoriasis with psoralens and ultraviolet A. A double\u2010blind comparison of 8\u2010me\u2010 thoxypsoralen and 5\u2010methoxypsora\u2010len","volume":"10","author":"Berg M","year":"1994","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"e_1_2_15_209_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2000.00589.x"},{"key":"e_1_2_15_210_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00460.x"},{"key":"e_1_2_15_211_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246849"},{"key":"e_1_2_15_212_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.024"},{"key":"e_1_2_15_213_2","first-page":"401","article-title":"[Photo\u2010 chemotherapy by 8\u2010methoxypsoralen and UVA in psoriasis vulgaris\u2014clini\u2010 cal experiences in 5 dermatological departments of GDR (author's transl)]","volume":"164","author":"Barth J","year":"1978","journal-title":"Dermatol Monatsschr."},{"key":"e_1_2_15_214_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02328.x"},{"key":"e_1_2_15_215_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2000.00913.x"},{"key":"e_1_2_15_216_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1988.tb03652.x"},{"key":"e_1_2_15_217_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199809000-00020"},{"key":"e_1_2_15_218_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197811000-00009"},{"key":"e_1_2_15_219_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12319272"},{"key":"e_1_2_15_220_2","first-page":"351","article-title":"Calcipotriol in combination with PUVA: A randomized double blind placebo study in severe psoriasis","volume":"3","author":"Frappaz A","year":"1993","journal-title":"Eur J Dermatol."},{"key":"e_1_2_15_221_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70085-2"},{"key":"e_1_2_15_222_2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archderm.1979.04010090024017","article-title":"Combination therapy for psoriasis. Psoralens plus long\u2010wave ultraviolet radiation with betamethasone valerate","volume":"115","author":"Hanke CW","year":"1979","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_223_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107940"},{"key":"e_1_2_15_224_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05653.x"},{"key":"e_1_2_15_225_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1978.tb01512.x"},{"key":"e_1_2_15_226_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)90820-1"},{"key":"e_1_2_15_227_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb07470.x"},{"key":"e_1_2_15_228_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.027"},{"key":"e_1_2_15_229_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.09.010"},{"key":"e_1_2_15_230_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08236.x"},{"key":"e_1_2_15_231_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08315.x"},{"key":"e_1_2_15_232_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.00236.x"},{"key":"e_1_2_15_233_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.12.003"},{"key":"e_1_2_15_234_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630801955358"},{"key":"e_1_2_15_235_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463200902200125"},{"key":"e_1_2_15_236_2","first-page":"411\u20146","article-title":"[Recommendations for tuberculosis screening before initiation of TNF\u2010alpha\u2010inhibitor treatment in rheumatic diseases]","volume":"68","author":"Diel R","year":"2009","journal-title":"Z Rheumatol."},{"key":"e_1_2_15_237_2","first-page":"1047","article-title":"[Influence of cyclosporin A on psoriasis]","volume":"104","author":"Muller W","year":"1979","journal-title":"Dtsch Med Wochenschr."},{"key":"e_1_2_15_238_2","first-page":"88\u201495","article-title":"A randomized, double\u2010blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandim\u2010 mun, in patients with severe psoriasis. OLP302 Study Group","volume":"139","author":"Koo J","year":"1998","journal-title":"Br J Derma- tol."},{"issue":"69","key":"e_1_2_15_239_2","first-page":"3\u201417","article-title":"Biological therapies in the systemic management of psoriasis: International Consensus Conference","volume":"151","author":"Sterry W","year":"2004","journal-title":"Br J Dermatol."},{"key":"e_1_2_15_240_2","volume-title":"Ciclosporin in der Dermatologie","author":"Mrowietz U","year":"2003"},{"key":"e_1_2_15_241_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91335-9"},{"key":"e_1_2_15_242_2","first-page":"148\u20149","article-title":"Intralesional cyclosporin in psoriasis","volume":"146","author":"Powles AV","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)."},{"key":"e_1_2_15_243_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90061-O"},{"key":"e_1_2_15_244_2","doi-asserted-by":"publisher","DOI":"10.1159\/000066425"},{"key":"e_1_2_15_245_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2007.00305.x"},{"key":"e_1_2_15_246_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630701418747"},{"key":"e_1_2_15_247_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.112400"},{"key":"e_1_2_15_248_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90189-2"},{"key":"e_1_2_15_249_2","first-page":"341\u201443","article-title":"Comparison of two therapeutic regimens, continous monotherapy and intermittent therapy, for long\u2010term maintenance of remission of psoriasis with cyclosporin A","volume":"6","author":"Nakayama J","year":"1996","journal-title":"Eur J Dermatol."},{"key":"e_1_2_15_250_2","doi-asserted-by":"crossref","first-page":"1203\u20148","DOI":"10.1111\/j.1468-3083.2007.02226.x","article-title":"Intermittent vs. continuous 1\u2010year cyclosporin use in chronic plaque psoriasis","volume":"21","author":"Chaidemenos GC","year":"2007","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"e_1_2_15_251_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101313240501"},{"key":"e_1_2_15_252_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04131.x"},{"key":"e_1_2_15_253_2","first-page":"486\u20149","article-title":"[Results of cyclos\u2010 porin treatment of severe, chronic psoriasis vulgaris]","volume":"40","author":"Engst R","year":"1989","journal-title":"Hautarzt."},{"key":"e_1_2_15_254_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247286"},{"key":"e_1_2_15_255_2","first-page":"116\u201421","article-title":"Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial","volume":"158","author":"Flytstrom I","year":"2008","journal-title":"Br J Dermatol."},{"key":"e_1_2_15_256_2","doi-asserted-by":"crossref","first-page":"1242\u20147","DOI":"10.3945\/ajcn.2008.26427","article-title":"Weight loss improves the response of obese patients with moderate\u2010to\u2010severe chronic plaque psoriasis to low\u2010dose cyclosporine therapy: a randomized, controlled, investigator\u2010 blinded clinical trial","volume":"88","author":"Gisondi P","year":"2008","journal-title":"Am J Clin Nutr."},{"key":"e_1_2_15_257_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021359"},{"key":"e_1_2_15_258_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb02935.x"},{"key":"e_1_2_15_259_2","doi-asserted-by":"crossref","first-page":"65\u20149","DOI":"10.2340\/00015555756569","article-title":"Remission of ordinary psoriasis following a short clearance course of cyclosporin","volume":"75","author":"Levell NJ","year":"1995","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_260_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/0001555577137141","article-title":"Low\u2010dose (1.25 mg\/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile","volume":"77","author":"Meffert H","year":"1997","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_261_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2001.04376.x"},{"key":"e_1_2_15_262_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70154-7"},{"key":"e_1_2_15_263_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70138-5"},{"key":"e_1_2_15_264_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb01402.x"},{"key":"e_1_2_15_265_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2006.00571.x"},{"key":"e_1_2_15_266_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0887-5"},{"key":"e_1_2_15_267_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0216"},{"key":"e_1_2_15_268_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb01481.x"},{"key":"e_1_2_15_269_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463200401700321"},{"key":"e_1_2_15_270_2","first-page":"221","article-title":"Sequential treatment of psoriasis with infliximab followed by cyclosporin. Preliminary results of an open\u2010label prospective study","volume":"141","author":"Vena GA","year":"2006","journal-title":"G Ital Dermatol Venereol."},{"key":"e_1_2_15_271_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00870.x"},{"key":"e_1_2_15_272_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0007-0963.2004.05739.x"},{"key":"e_1_2_15_273_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02976.x"},{"key":"e_1_2_15_274_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1998.tb00714.x"},{"key":"e_1_2_15_275_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06179-7"},{"key":"e_1_2_15_276_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12040.x"},{"key":"e_1_2_15_277_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00519_12.x"},{"key":"e_1_2_15_278_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02030.x"},{"key":"e_1_2_15_279_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06244.x"},{"key":"e_1_2_15_280_2","first-page":"115","article-title":"Serum TNF\u2010alpha levels correlate with disease severity and are reduced by effective therapy in plaque\u2010type psoriasis","volume":"11","author":"Mussi A","year":"1997","journal-title":"J Biol Regul Homeost Agents."},{"key":"e_1_2_15_281_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20335"},{"key":"e_1_2_15_282_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00004"},{"key":"e_1_2_15_283_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1627"},{"key":"e_1_2_15_284_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030409"},{"key":"e_1_2_15_285_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06688.x"},{"key":"e_1_2_15_286_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67763-X"},{"key":"e_1_2_15_287_2","first-page":"1177\u201485","article-title":"Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate\u2010to\u2010severe plaque psoriasis: a randomized controlled trial with open\u2010label extension","volume":"159","author":"van de Kerkhof PC","year":"2008","journal-title":"Br J Dermatol."},{"key":"e_1_2_15_288_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630601121086"},{"key":"e_1_2_15_289_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9233-0"},{"key":"e_1_2_15_290_2","first-page":"225\u20149","article-title":"Once\u2010weekly administration of high\u2010 dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study)","volume":"19","author":"Cassano N","year":"2006","journal-title":"Int J Immun- opathol Pharmacol."},{"key":"e_1_2_15_291_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08564.x"},{"key":"e_1_2_15_292_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.002"},{"key":"e_1_2_15_293_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08618.x"},{"key":"e_1_2_15_294_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463200902200214"},{"key":"e_1_2_15_295_2","first-page":"187\u20149","article-title":"Safety and efficacy study on etanercept in patients with plaque psoriasis","volume":"152","author":"Costanzo A","year":"2005","journal-title":"Br J Dermatol."},{"key":"e_1_2_15_296_2","first-page":"191\u20146","article-title":"Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open\u2010label study","volume":"36","author":"Koc E","year":"2009","journal-title":"J Der- matol."},{"key":"e_1_2_15_297_2","first-page":"245\u201453","article-title":"Utilization of narrow\u2010band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient\u2010reported outcomes","volume":"7","author":"Kircik L","year":"2008","journal-title":"J Drugs Dermatol."},{"key":"e_1_2_15_298_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0511"},{"key":"e_1_2_15_299_2","first-page":"44","article-title":"Global safety and efficacy of up to five years of etanercept (Enbrel) therapy","author":"Klareskog L","year":"2001","journal-title":"Arthritis Rheum."},{"key":"e_1_2_15_300_2","first-page":"533","article-title":"Etanercept (Enbrel) mono\u2010 therapy for more than 5 years in patients with DMARD\u2010refrectory rheumatoid arthritis","volume":"46","author":"Moreland LW","year":"2002","journal-title":"Arthritis Rheum."},{"key":"e_1_2_15_301_2","first-page":"61","article-title":"Tuberculosis reports with etanercept (Enbrel) therapy","author":"Holman J","year":"2002","journal-title":"Ann Dis Rheum."},{"key":"e_1_2_15_302_2","unstructured":"Fachinformation Wyeth. aktuelle Version."},{"key":"e_1_2_15_303_2","first-page":"2792","article-title":"Safety and efficacy of over 7 years of etanercept therapy in a global population of patients with rheumatoid arthritis","volume":"52","author":"Lebwohl M","year":"2005","journal-title":"J Am Acad Dermatol."},{"key":"e_1_2_15_304_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2004.11.003"},{"key":"e_1_2_15_305_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.6570"},{"key":"e_1_2_15_306_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05153.x"},{"key":"e_1_2_15_307_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01159.x"},{"key":"e_1_2_15_308_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050251"},{"key":"e_1_2_15_309_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260916"},{"key":"e_1_2_15_310_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02400.x"},{"key":"e_1_2_15_311_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1747.2003.12605.x"},{"key":"e_1_2_15_312_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70121-0"},{"key":"e_1_2_15_313_2","doi-asserted-by":"publisher","DOI":"10.1159\/000063148"},{"key":"e_1_2_15_314_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80228-9"},{"key":"e_1_2_15_315_2","first-page":"2387","article-title":"[Fumaric acid therapy in psoriasis; a double\u2010blind, placebo\u2010controlled study]","volume":"134","author":"Nugteren\u2010Huying WM","year":"1990","journal-title":"Ned Tijdschr Geneeskd."},{"key":"e_1_2_15_316_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050401"},{"key":"e_1_2_15_317_2","first-page":"279","article-title":"[Peroral long\u2010term treatment of psoriasis using fumaric acid derivatives]","volume":"38","author":"Bayard W","year":"1987","journal-title":"Hautarzt."},{"key":"e_1_2_15_318_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310019346"},{"key":"e_1_2_15_319_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02124.x"},{"key":"e_1_2_15_320_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70071-2"},{"key":"e_1_2_15_321_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05433.x"},{"key":"e_1_2_15_322_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.07120_supp.x"},{"key":"e_1_2_15_323_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032268"},{"key":"e_1_2_15_324_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.02.021"},{"key":"e_1_2_15_325_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67566-6"},{"key":"e_1_2_15_326_2","first-page":"381","article-title":"Infliximab treatment improves productivity among patients with moderate\u2010to\u2010severe psoriasis","volume":"17","author":"Reich K","year":"2007","journal-title":"Eur J Dermatol."},{"key":"e_1_2_15_327_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04954-0"},{"key":"e_1_2_15_328_2","doi-asserted-by":"publisher","DOI":"10.1177\/039463200702000324"},{"key":"e_1_2_15_329_2","first-page":"9","article-title":"Diffuse psoriasis plaque type and infliximab: our experience and review of literature","volume":"142","author":"Lemme G","year":"2007","journal-title":"G Ital Dermatol Venereol."},{"key":"e_1_2_15_330_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120472"},{"key":"e_1_2_15_331_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.07.017"},{"key":"e_1_2_15_332_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070771"},{"key":"e_1_2_15_333_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08728.x"},{"key":"e_1_2_15_334_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05246-0"},{"key":"e_1_2_15_335_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410017275"},{"key":"e_1_2_15_336_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.09.012"},{"key":"e_1_2_15_337_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.07.042"},{"key":"e_1_2_15_338_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08686.x"},{"key":"e_1_2_15_339_2","unstructured":"Fachinformation essex pharma. aktuelle Version."},{"key":"e_1_2_15_340_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-195102000-00009"},{"key":"e_1_2_15_341_2","first-page":"1\u20142","article-title":"Systemic therapy of psoriasis using methotrexate","volume":"6","author":"Smith KC","year":"2000","journal-title":"Skin Therapy Lett."},{"key":"e_1_2_15_342_2","doi-asserted-by":"crossref","first-page":"33\u20148","DOI":"10.1001\/archderm.1971.04000130035004","article-title":"Methotrexate for psoriasis. A new therapeutic schedule","volume":"103","author":"Weinstein GD","year":"1971","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_343_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70508-0"},{"key":"e_1_2_15_344_2","doi-asserted-by":"crossref","first-page":"393\u20146","DOI":"10.2340\/0001555575393396","article-title":"Interruption of long\u2010term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral me\u2010 thotrexate","volume":"75","author":"van Dooren\u2010Greebe RJ","year":"1995","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_345_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70069-6"},{"key":"e_1_2_15_346_2","first-page":"CD000951","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","author":"Ortiz Z","year":"2000","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_2_15_347_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7"},{"key":"e_1_2_15_348_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07289.x"},{"key":"e_1_2_15_349_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0442-x"},{"key":"e_1_2_15_350_2","first-page":"295\u2014300","article-title":"Methotrexate versus hydroxycarbamide (hy\u2010 droxyurea) as a weekly dose to treat moderate\u2010to\u2010severe chronic plaque psoriasis: a comparative study","volume":"18","author":"Ranjan N","year":"2007","journal-title":"J Der- matolog Treat."},{"key":"e_1_2_15_351_2","doi-asserted-by":"crossref","first-page":"19\u201424","DOI":"10.1111\/j.1468-3083.2007.02264.x","article-title":"A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment","volume":"22","author":"Hroch M","year":"2008","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"e_1_2_15_352_2","first-page":"345\u201455","article-title":"Methotr\u2010 exate for psoriasis in weekly oral doses without any adjunctive therapy","volume":"140","author":"Nyfors A","year":"1970","journal-title":"Der-matologica."},{"key":"e_1_2_15_353_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.01.004"},{"key":"e_1_2_15_354_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(82)70157-4"},{"key":"e_1_2_15_355_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(82)70005-2"},{"key":"e_1_2_15_356_2","first-page":"204\u201410","article-title":"Methotrexate revisited: effects of long\u2010term treatment in psoriasis","volume":"130","author":"Van Dooren\u2010Greebe RJ","year":"1994","journal-title":"Br J Dermatol."},{"key":"e_1_2_15_357_2","first-page":"208\u201411","article-title":"Benefits and adverse drug experiences during long\u2010term me\u2010 thotrexate treatment of 248 psoria\u2010 tics","volume":"25","author":"Nyfors A","year":"1978","journal-title":"Dan Med Bull."},{"key":"e_1_2_15_358_2","doi-asserted-by":"crossref","first-page":"1218\u201424","DOI":"10.1001\/archderm.1989.01670210056007","article-title":"The role of liver biopsies in psoriatic patients receiving long\u2010term methotr\u2010 exate treatment. Improvement in liver abnormalities after cessation of treatment","volume":"125","author":"Newman M","year":"1989","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_359_2","first-page":"711\u20146","article-title":"Methotrexate and histologic hepatic abnormalities: a meta\u2010analysis","volume":"90","author":"Whiting\u2010O\u2019Keefe QE","year":"1991","journal-title":"Am J Med."},{"key":"e_1_2_15_360_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80148-4"},{"key":"e_1_2_15_361_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(97)00014-X"},{"key":"e_1_2_15_362_2","first-page":"774\u20148","article-title":"Sequential liver biopsies during longterm methotrexate treatment for psoriasis: a reappraisal","volume":"133","author":"Boffa MJ","year":"1995","journal-title":"Br J Dermatol."},{"key":"e_1_2_15_363_2","doi-asserted-by":"publisher","DOI":"10.1155\/1996\/213596"},{"key":"e_1_2_15_364_2","first-page":"511\u20148","article-title":"Liver biopsies from psoria\u2010 tics related to methotrexate therapy. 3. Findings in post\u2010methotrexate liver biopsies from 160 psoriatics","volume":"85","author":"Nyfors A","year":"1977","journal-title":"Acta Pathol Microbiol Scand A."},{"key":"e_1_2_15_365_2","doi-asserted-by":"crossref","first-page":"413\u20145","DOI":"10.1001\/archderm.1980.01640280049016","article-title":"Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals","volume":"116","author":"Robinson JK","year":"1980","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_366_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1975.tb06498.x"},{"key":"e_1_2_15_367_2","doi-asserted-by":"crossref","first-page":"291\u20146","DOI":"10.2340\/000155555291296","article-title":"Liver biopsy in methotrexate\u2010treated psoriatics\u2010a re\u2010evalution","volume":"55","author":"Zachariae H","year":"1975","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_368_2","first-page":"407\u201412","article-title":"Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment","volume":"102","author":"Zachariae H","year":"1980","journal-title":"Br J Dermatol."},{"key":"e_1_2_15_369_2","doi-asserted-by":"publisher","DOI":"10.1159\/000249793"},{"key":"e_1_2_15_370_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.10.2769"},{"key":"e_1_2_15_371_2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archderm.1985.01660100077019","article-title":"Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis","volume":"121","author":"Moy RL","year":"1985","journal-title":"Arch Dermatol."},{"key":"e_1_2_15_372_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70198-X"},{"key":"e_1_2_15_373_2","first-page":"35","article-title":"A double\u2010blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study","volume":"69","author":"Kragballe K","year":"1989","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_374_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1988.tb02429.x"},{"key":"e_1_2_15_375_2","first-page":"176","article-title":"Acitretin in the treatment of severe psoriasis: a randomized double\u2010blind study comparing acitretin and etretinate","volume":"146","author":"Meffert H","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)."},{"key":"e_1_2_15_376_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70086-9"},{"key":"e_1_2_15_377_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-096438"},{"key":"e_1_2_15_378_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1145697"},{"key":"e_1_2_15_379_2","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.11.5.601"},{"key":"e_1_2_15_380_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(97)00013-8"},{"key":"e_1_2_15_381_2","first-page":"707","article-title":"Management of guttate and generalized psoriasis vulgaris: prospective randomized study","volume":"43","author":"Caca\u2010Biljanovska NG","year":"2002","journal-title":"Croat Med J."},{"key":"e_1_2_15_382_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70138-9"},{"key":"e_1_2_15_383_2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.5"},{"key":"e_1_2_15_384_2","doi-asserted-by":"publisher","DOI":"10.1159\/000248567"},{"key":"e_1_2_15_385_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb01406.x"},{"key":"e_1_2_15_386_2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2340\/00015555-0529","article-title":"A randomized comparison of acitretin\u2010narrow\u2010band TL\u201001 phototherapy and acitretin\u2010 psoralen plus ultraviolet A for psoriasis","volume":"88","author":"Ozdemir M","year":"2008","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_387_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.4.436"},{"key":"e_1_2_15_388_2","doi-asserted-by":"publisher","DOI":"10.1159\/000248398"},{"key":"e_1_2_15_389_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70362-2"},{"key":"e_1_2_15_390_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70089-K"},{"key":"e_1_2_15_391_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03883.x"},{"key":"e_1_2_15_392_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70091-F"},{"key":"e_1_2_15_393_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60725-4"},{"key":"e_1_2_15_394_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60726-6"},{"key":"e_1_2_15_395_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60140-9"},{"key":"e_1_2_15_396_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8019.2003.01622.x"},{"key":"e_1_2_15_397_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0340"},{"key":"e_1_2_15_398_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03278.x"},{"key":"e_1_2_15_399_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1996.0069"},{"key":"e_1_2_15_400_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017515"},{"key":"e_1_2_15_401_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-8343(89)90036-4"},{"key":"e_1_2_15_402_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017504"},{"key":"e_1_2_15_403_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.9.1221"},{"key":"e_1_2_15_404_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb04192.x"},{"key":"e_1_2_15_405_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057974"},{"key":"e_1_2_15_406_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.111850"},{"key":"e_1_2_15_407_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04622.x"},{"key":"e_1_2_15_408_2","doi-asserted-by":"publisher","DOI":"10.1159\/000012336"},{"key":"e_1_2_15_409_2","doi-asserted-by":"crossref","first-page":"361\u201470","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond AS","year":"1983","journal-title":"Acta Psychiatr Scand."},{"key":"e_1_2_15_410_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1992.01680160143028"},{"key":"e_1_2_15_411_2","first-page":"49\u201455","article-title":"Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques","volume":"32","author":"Ilknur T","year":"2006","journal-title":"Der-matol Surg."},{"key":"e_1_2_15_412_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06827.x"},{"key":"e_1_2_15_413_2","first-page":"55\u201460","article-title":"The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308\u2010nm excimer laser sessions","volume":"18","author":"Trott J","year":"2008","journal-title":"Eur J Dermatol."},{"key":"e_1_2_15_414_2","first-page":"290","article-title":"Optimization of narrow\u2010band uvb with a 5% oleic acid cream in the treatment of psoriasis","volume":"6","author":"Martin\u2010Ezquerra G","year":"2007","journal-title":"J Drugs Dermatol."},{"key":"e_1_2_15_415_2","doi-asserted-by":"crossref","first-page":"241\u20144","DOI":"10.2340\/0001555559241244","article-title":"Oral retinoid and UVB radiation: a new, alternative treatment for psoriasis on an out\u2010patient basis","volume":"59","author":"Orfanos CE","year":"1979","journal-title":"Acta Derm Venereol."},{"key":"e_1_2_15_416_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2009.01250.x"},{"issue":"1","key":"e_1_2_15_417_2","first-page":"S31\u20148","article-title":"Balneotherapy for chronic plaque psoriasis at Comano spa in Trentino, Italy","volume":"21","author":"Peroni A","year":"2008","journal-title":"Dermatol Ther."},{"key":"e_1_2_15_418_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1997.tb00509.x"},{"key":"e_1_2_15_419_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70214-2"},{"key":"e_1_2_15_420_2","first-page":"325\u20148","article-title":"Narrowband UV\u2010B (TL\u201001) phototherapy vs oral 8\u2010methoxypsoralen psoralen\u2010UV\u2010A for the treatment of chronic plaque psoriasis","volume":"139","author":"Markham T","year":"2003","journal-title":"Arch Der-matol."},{"key":"e_1_2_15_421_2","first-page":"26\u201431","article-title":"Comparison of PUVA and UVB therapy in moderate plaque psoriasis","author":"ul Bari A","year":"2005","journal-title":"J Pak Assoc Dermatol."},{"key":"e_1_2_15_422_2","doi-asserted-by":"publisher","DOI":"10.1080\/13547500701600597"},{"key":"e_1_2_15_423_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1992.tb00071.x"},{"key":"e_1_2_15_424_2","first-page":"853\u20147","article-title":"Oral 8\u2010methoxyp\u2010 soralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres","volume":"1","author":"Henseler T","year":"1981","journal-title":"Lancet."},{"key":"e_1_2_15_425_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.02718.x"},{"key":"e_1_2_15_426_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410023322"},{"key":"e_1_2_15_427_2","first-page":"126\u20149","article-title":"Twice\u2010 vs. thrice\u2010weekly MPD PUVA in psoriasis: a randomized\u2010controlled efficacy study","volume":"23","author":"Valbuena MC","year":"2007","journal-title":"Photodermatol Pho- toimmunol Photomed"},{"key":"e_1_2_15_428_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07316.x"},{"key":"e_1_2_15_429_2","doi-asserted-by":"publisher","DOI":"10.1177\/1721727X0500300108"},{"key":"e_1_2_15_430_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.09.012"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2012.07919.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2012.07919.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T13:15:13Z","timestamp":1742649313000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2012.07919.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":429,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1111\/j.1610-0387.2012.07919.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2012.07919.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}